Fig. 3From: Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA‘Severe impairment’ of QoL at study baseline and end of cycle 3 (FAS). EQ-5D, EuroQol 5-dimensions questionnaire, three-level; FAS, full analysis set; n, number of observed cases; QoL, quality of lifeBack to article page